Miamo Brings Its Italian Clinical Skincare Philosophy to the United Kingdom

Contemporary beauty is experiencing a quiet transformation. Fewer excesses, fewer unrealistic promises, and a growing demand for science, efficacy, and truly personalised treatments. It is within this landscape that Miamo officially arrives in the United Kingdom, bringing with it a sophisticated clinical approach that has already established a strong presence within the Italian skincare market.

Founded in 2012 by pharmacists Dr Elena Aceto di Capriglia and Dr Camilla D’Antonio, the brand was created with a very clear concept: to unite advanced scientific research, personalised dermatological protocols, and an extremely individualised vision of skin health. From the very beginning, Miamo was built as a family managed company and remains entirely overseen by the founding family today, including Giovanni D’Antonio, who leads the strategic direction of the brand.

Recently, I had the pleasure of attending, at the invitation of the brand, an intimate breakfast experience at The Peninsula London, representing Avesso Magazine during Miamo’s official presentation in the United Kingdom. The event took place in partnership with The Public Platform, the agency responsible for the brand’s communication strategy in the British market, and marked not only the launch of Miamo’s e commerce platform in the UK, but also a deeper introduction to the scientific and clinical philosophy that defines the identity of the Italian label.

During the event, I also had the pleasure of meeting Dr Camilla D’Antonio, co founder of Miamo, who shared fascinating insights into the brand’s methodology and her perspective on the future of contemporary clinical aesthetics.

Unlike traditional skincare models built around generic routines and temporary trends, Miamo operates through a protocol based methodology, developing personalised treatments according to the specific needs of each individual skin type. The philosophy of the brand is not centred around the indiscriminate use of countless products at once, but rather on the creation of intelligent and strategic protocols, combining active ingredients according to each patient’s unique characteristics.

During the presentation, Dr Camilla explained that one of Miamo’s greatest differentiators lies precisely in its ability to treat multiple skin concerns simultaneously. Sensitivity, melasma, couperose, acne, wrinkles, hyperpigmentation and dehydration can all coexist within the same skin, and according to her, it makes little sense to approach each concern in isolation.

The construction of each protocol happens gradually, respecting the physiological response of the skin. Initially, patients may begin with minimal stimulation, such as one serum in the morning and another in the evening. As the skin evolves, new active ingredients and stronger stimuli are strategically introduced.

There is something particularly sophisticated about the way Miamo interprets clinical aesthetics. The brand does not simply work with cosmetics, but with a much broader vision surrounding skin balance, dermatological education and prevention.

Another point that stood out during the discussion was the brand’s attention to subjects that remain relatively overlooked within the traditional beauty industry, particularly the impact of blue light and heat exposure on skin health. Dr Camilla highlighted the importance of iron oxide within some of the brand’s sunscreen formulations, an ingredient that assists in protecting the skin against blue light emitted by mobile phones, computers and digital screens.

According to her, scientific studies increasingly demonstrate that this type of exposure can aggravate pigmentation disorders, particularly melasma and hyperpigmentation. In addition, factors such as excessive heat, hypervascularisation, saunas and even certain medications may trigger inflammatory and vascular skin conditions.

Among the most interesting aspects presented during the event was the extremely rigorous distinction between Miamo’s professional protocols and its home care products. According to Dr Camilla, very few companies within the market currently maintain such a specific separation between professional treatments and domestic skincare, especially within the advanced clinical aesthetics sector.

Miamo works directly alongside clinics, doctors and specialised professionals, creating personalised protocols capable of addressing multiple concerns simultaneously without compromising the skin’s balance. The idea is not to overwhelm patients with endless products, but to develop intelligent and progressive combinations of active ingredients according to the clinical evolution of each case.

Another relevant subject discussed during the presentation was the brand’s growing concern with contemporary issues linked to skin health, including the effects of blue light emitted by electronic devices and the impact of excessive heat on vascular and pigment related skin conditions.

According to Dr Camilla, factors such as hypervascularisation, intense thermal exposure, saunas and even certain medications may aggravate conditions such as melasma, redness and couperose. Within this approach, the brand emphasises the importance of iron oxide within selected sunscreen formulas, an ingredient widely associated with blue light protection and frequently recommended by dermatologists for patients predisposed to hyperpigmentation.

Miamo’s philosophy clearly moves against the superficial idea of skincare as merely an aesthetic ritual. There is an evident focus on functionality, skin longevity and treatments grounded in real scientific evidence.

Beyond research and product formulation, the brand also demonstrates a growing interest in sustainability, logistics, innovation and responsibility within the beauty industry. During the event, Dr Camilla also mentioned the company’s recent entry into the Beauty Council in London, participating in discussions surrounding the future of sustainability within the sector.

With an already established presence in Italy, Miamo’s arrival in the United Kingdom feels highly aligned with the new luxury consumer, increasingly interested in transparency, efficacy and long term personalised treatments.

More than simply following trends, Miamo appears genuinely interested in shaping a new language within contemporary clinical aesthetics, where science, personalisation and sophistication coexist in an entirely natural way.